Neopharm Reports Operating Profit of 3.6 Billion KRW in 3Q, Down 28.1% Year-on-Year
[Asia Economy Reporter Kang Nahum] Neopharm announced on the 6th that its consolidated operating profit for the third quarter of this year was preliminarily estimated at 3.6 billion KRW, a 28.1% decrease compared to the same period last year.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Sales amounted to 17.9 billion KRW, down 6.3% from the same period last year, and net profit decreased by 28.8% to 3 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
